- Home >
- Clinicals Trials >
- BFR ESS 01
Retour à la liste des essais cliniquesSarcomas
BFR ESS 01
Randomized Comparative Prospective Multicentre Phase II Trial Evaluating Clinical Impact of Interruption VS Maintenance of AI in Patients With Locally Advanced/ Metastatic LGESS
- Ouvert à Paris depuis le : 11/07/2019
- Public cible : Adult
- Phase : Phase II
Description de l'essai
The primary objective is to compare the progression-free survival (PFS) between aromatase inhibitors interruption and aromatase inhibitors maintenance strategies in patients with a locally advanced or metastatic Low Grade Endometrial Stromal Sarcoma (LGESS).
Url of the trial